TCG Crossover Management »

Relay Therapeutics shares owned by TCG Crossover Management

Quarter-by-quarter ownership of Relay Therapeutics (RLAY) shares owned by TCG Crossover Management from 13F filings

Historical chart of TCG Crossover Management investment in Relay Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Relay Therapeutics held by TCG Crossover Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Relay Therapeutics by TCG Crossover Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $9.5M 1.8M 5.22

More positions owned by TCG Crossover Management

Abivax Sa American Depositary Shares Adrs (ABVX)
Cg Oncology Comm (CGON)
Cogent Biosciences Comm (COGT)
Amylyx Pharmaceuticals Comm (AMLX)
Centessa Pharmaceuticals Adrs (CNTA)
Tango Therapeutics Comm (TNGX)
Ocular Therapeutix Comm (OCUL)
Dianthus Therapeutics Comm (DNTH)
Tourmaline Bio Comm (TRML)
Dyne Therapeutics Comm (DYN)
Agios Pharmaceuticals Comm (AGIO)
Eyepoint Pharmaceuticals Comm (EYPT)
Fulcrum Therapeutics Comm (FULC)
Savara Comm (SVRA)
Rapt Therapeutics Comm (RAPT)

View all positions for TCG Crossover Management

Top funds holding Relay Therapeutics

Sb Investment Advisers
Commodore Capital
Point72 Asset Management
BlackRock
Casdin Capital
Vanguard Group
Bellevue Group
Tang Capital Management
State Street Corporation
Nextech Invest
Geode Capital Management
Kynam Capital Management
Dimensional Fund Advisors
MPM Oncology Impact Management
Goldman Sachs Group

View all funds holding Relay Therapeutics